• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 20
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 20
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    SARS-CoV-2 R&D: Is It Over?

    Sustainability: A New Threat or Opportunity for CDMOs?

    Advanced Therapy Manufacturing

    Advanced Therapy Packaging Trends

    CEO Spotlight: Darren Head
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    iECURE Enters Agreement with Center for Breakthrough Medicines

    CPDC Enters Clinical Manufacturing Deal with CellBion

    Olon to Build New R&D Center in Italy

    Hanmi Fine Chemical Launches CDMO Business

    DFE Pharma Opens India CoE for Fast-Track Formulation Services
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    iECURE Enters Agreement with Center for Breakthrough Medicines

    CPDC Enters Clinical Manufacturing Deal with CellBion

    Olon to Build New R&D Center in Italy

    Hanmi Fine Chemical Launches CDMO Business

    DFE Pharma Opens India CoE for Fast-Track Formulation Services
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Selecting a CMO Partner for Sterile Injectable Manufacturing

    Royalty Pharma and Jefferies Invest $111M in ApiJect

    Cryoport Acquires Cell&Co BioServices for €6.2M

    Challenges of Developing Large Volume Drug/Device Combination Products for Parenteral SC Delivery

    Yourway Adds Capacity for Controlled Ambient Storage
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Hanmi Fine Chemical Launches CDMO Business

    DFE Pharma Opens India CoE for Fast-Track Formulation Services

    Helsinn Establishes New R&D Hub in the U.S.

    CureVac, myNEO Partner on Antigen Targets for mRNA-Cancer Vax Development

    How Can Automation Optimize Immunohistochemistry?
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    FDA Inspection Trends Update

    Phase-Appropriate cGMP Considerations for Cell and Gene Therapy

    Sustainability: A New Threat or Opportunity for CDMOs?

    In Pursuit of Sustainability: How the Biopharma Industry Can Contribute

    Conducting Clinical Trials During the Pandemic: What Did We Learn?
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Kyongbo Pharmaceutical

    Vector Partners Limited

    IDT Biologika

    Alcami

    CMC Pharmaceuticals
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Kyongbo Pharmaceutical

    Vector Partners Limited

    IDT Biologika

    Alcami

    CMC Pharmaceuticals
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Podcasts
    • Infographics
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    India Report

    HPAPI Outsourcing Likely to Gain Traction

    A number of highly potent drugs will soon fall into the generic domain

    HPAPI Outsourcing Likely to Gain Traction
    Related CONTENT
    • Taros Chemicals GmbH & Co. KG
    • Sekisui
    • Ardena Acquires Idifarma from Suanfarma and Sodena
    • Syngene
    • Idifarma Launches Accelerated Pathway for Complex Drugs
    S. Harachand, Contributing Editor09.11.18
    Faster growth of the therapeutic segments offering drugs to treat cancer and hormonal disorders are pushing up the demand for sourcing high potency APIs. Even though the majority of facilities producing cytotoxic compounds are located in North America and European countries, companies are turning their focus to developing nations for low-cost processes. Players from Asia-Pacific nations, including India, are expected to benefit as the proportion of firms outsourcing to locations with low-cost production technology increases. The region, noted for its booming HPAPI manufacturing, is a traditionally known hub for cost-competitive generic products.

    India, the generic powerhouse, stands alongside Japan and China as a favorable destination for HPAPI services in the Asia-Pacific region. HPAPI manufacturing in these parts is forecast to grow a little higher than the global average.

    The Asian region is expected to grow at the highest CAGR of 11.8% while the global HPAPIs market is poised to reach $26.84 billion by 2023 from $17.72 billion in 2018 growing at a CAGR of 8.7%, according to a recent report by Research and Markets. The growing market for contract manufacturers in this region, owing to low labor and manufacturing costs, helps the promotion of HPAPIs, among other things.

    Many innovators are on the lookout for facilities that have the capabilities and safety standards to handle HPAPIs for high growth segments such as oncology. CDMOs with integrated capabilities in HPAPIs will have a competitive edge over others as they can add value to companies outsourcing these products in terms of cost and timelines. Undoubtedly, end-to-end service providers that can take care of the entire product lifecycle from discovery to commercialization stand to gain.

    Piramal Pharma Solutions, for instance, started offering HPAPI services following its acquisition of Ash Stevens, the Riverview, MI-based contract manufacturer in August 2016. Currently, Piramal provides services ranging from conjugation development to clinical and commercial batch manufacturing and fill/finish to firms located in North America, Europe and Japan.

    Ash Stevens’ state-of-the-art manufacturing facility in Michigan has the containment controls for the safe handling and cGMP manufacture of small- and large-scale HPAPIs. Ash Stevens’ track record as a leader in HPAPIs with over five decades of experience in safe handling of potent compounds has proven to be a valuable addition to Piramal. Safety and containment requirements are very high to minimize the risk of handling HPAPIs. Piramal is, reportedly, planning to expand HPAPI capabilities at the Riverview facility.

    Piramal is also a noted player in antibody drug conjugates (ADCs) development. ADCs are highly potent biopharmaceutical drugs that link complex biological molecules like mAbs with cytotoxic drugs. ADCs have emerged as a promising class of anti-cancer therapeutics due to their high specificity in delivering cytotoxic/HPAPI drugs to target cells while significantly reducing the side-effects compared to chemotherapies. Steadily increasing demand for ADCs is also fueling the growth of HPAPIs.

    Dishman is another player that has expanded HPAPI capabilities through an outbound acquisition. The Ahmedabad-based CMO bought out Carbogen Amcis in 2007. The Swiss firm started a high containment factory at Bavla, in the western Indian state of Gujarat. With containment facilities spread across India, The Netherlands, Switzerland and China, Dishman Group is doing contract manufacturing and development of highly-potent compounds of all categories including cytostatics/cytotoxics.

    Several other players including Dr. Reddy’s, Neuland Labs, Arch Labs, and Syngene have capabilities to develop high potency compounds too.

    CMO investment in HPAPI facilities in India continues to be low despite the fact that the innovators prefer to outsource these potent agents from specialized manufacturers. The reason seems, primarily, because of the high level of safety standards and the requirement of specialized facilities. Apart from elaborate operating procedures, comprehensive quality management systems, and highly trained staff, it is also essential to have appropriate personnel protective equipment after evaluating occupational exposure to a compound and industrial hygiene programs for running HPAPI facilities.

    The absence of a global regulatory framework for handling HPAPIs is another challenge faced by the companies operating in this space.

    However, more CMOs are likely to be driven to HPAPIs in the days to come as a considerable number of highly potent drugs including the anti-cancer mAbs will soon fall into the generic domain, losing their patent protection.


    S. Harachand
    Contributing Editor

    S. Harachand is a pharmaceutical journalist based in Mumbai. He can be reached at harachand@gmail.com.
    Related Searches
    • facility
    • High Potency
    • conjugation
    • hpapi manufacturing
    Suggested For You
    Taros Chemicals GmbH & Co. KG Taros Chemicals GmbH & Co. KG
    Sekisui Sekisui
    Ardena Acquires Idifarma from Suanfarma and Sodena Ardena Acquires Idifarma from Suanfarma and Sodena
    Syngene Syngene
    Idifarma Launches Accelerated Pathway for Complex Drugs Idifarma Launches Accelerated Pathway for Complex Drugs
    Solubility Enhancement of Hydrophobic Drugs and APIs Using Hot Melt Extrusion Solubility Enhancement of Hydrophobic Drugs and APIs Using Hot Melt Extrusion
    Oakwood Labs Oakwood Labs
    Idifarma Strengthens Spray Drying Capabilities Idifarma Strengthens Spray Drying Capabilities
    Piramal Pharma Solutions Piramal Pharma Solutions
    Vetio Animal Health Vetio Animal Health
    HPAPI Technology Evolution HPAPI Technology Evolution
    HPAPI Market Trends HPAPI Market Trends
    An “All-You-Can-Eat” Buffet for Excellence An “All-You-Can-Eat” Buffet for Excellence
    Are Indian Generic Firms Improving Compliance? Are Indian Generic Firms Improving Compliance?
    10	Lilly 10 Lilly

    Related Content

    • Taros Chemicals GmbH & Co. KG

      ...
      Dimitrios Tzalis, Manager Executive Projects 12.07.21

    • Sekisui

      ...
      Jim Alferman, Associate Director, Business Development 10.13.21

    • Breaking News | Cytotoxics and High Potency Manufacturing | Industry News
      Ardena Acquires Idifarma from Suanfarma and Sodena

      Ardena Acquires Idifarma from Suanfarma and Sodena

      Adds spray drying technology and high potency capabilities.
      09.02.21


    • Syngene

      Syngene

      ...
      Manish, Yadav 07.14.21

    • Breaking News | Cytotoxics and High Potency Manufacturing | Industry News | Solid Dosage/Creams/Ointments
      Idifarma Launches Accelerated Pathway for Complex Drugs

      Idifarma Launches Accelerated Pathway for Complex Drugs

      ‘Simply to Clinic’ leverages expertise in oral standard and highly potent drugs to take projects from pre-formulation to clinical trials.
      07.14.21

      Trending
      • How Can Automation Optimize Immunohistochemistry? | Contract Pharma
      • Catalyst Biosciences Sells Complement Portfolio To Vertex Pharmaceuticals | Contract Pharma
      • Corealis CDMO Completes Deal With ArchiMed | Contract Pharma
      • Mirum Pharmaceuticals Acquires San Diego-based Satiogen | Contract Pharma
      • CureVac, MyNEO Partner On Antigen Targets For MRNA-Cancer Vax Development | Contract Pharma
      Breaking News
      • iECURE Enters Agreement with Center for Breakthrough Medicines
      • CPDC Enters Clinical Manufacturing Deal with CellBion
      • Olon to Build New R&D Center in Italy
      • Hanmi Fine Chemical Launches CDMO Business
      • DFE Pharma Opens India CoE for Fast-Track Formulation Services
      View Breaking News >
      CURRENT ISSUE

      May 2022

      • Sustainability and the Biopharma Industry
      • Contract Manufacturing During COVID
      • Orphan Drugs in the United States
      • CEO Spotlight: Peter DeYoung
      • CEO Spotlight: Darren Head
      • Advanced Therapy Packaging Trends
      • Advanced Therapy Manufacturing
      • Sustainability: A New Threat or Opportunity for CDMOs?
      • SARS-CoV-2 R&D

      Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
      You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

      • About Us
      • Privacy Policy
      • Terms And Conditions
      • Contact Us

      follow us

      Subscribe
      Nutraceuticals World

      Latest Breaking News From Nutraceuticals World

      Thorne Relaunches Gut Health Test with Microbiome Wipe
      Alkemist Labs Announces Alkemist Assured Seal and Next Generation Transparency Reports
      GC Rieber Foundations Expand Philanthropic Efforts
      Coatings World

      Latest Breaking News From Coatings World

      ICP Receives ASC Innovation Award for Spray Foam That Meets Changing Environmental Regulations
      Pylon Coatings Uses Polygiene Biomaster & Verimaster for Antimicrobial Surface Protection
      Sto Corp. Recognized with Multiple Honors at the EIFS Hero Awards
      Medical Product Outsourcing

      Latest Breaking News From Medical Product Outsourcing

      New Breast Implant Surgery Guidelines to Enhance Patient Safety
      Rhythm Management Group Debuts RhythmSynergy Tech Platform
      FDA Approves Trial Completion for Virtual Incision's MIRA Platform
      Contract Pharma

      Latest Breaking News From Contract Pharma

      Olon to Build New R&D Center in Italy
      Hanmi Fine Chemical Launches CDMO Business
      DFE Pharma Opens India CoE for Fast-Track Formulation Services
      Beauty Packaging

      Latest Breaking News From Beauty Packaging

      K-Beauty Brand Siita Shares Plastic Decomposition Technology with the Beauty Industry
      Shellworks Raises $6.2 Million in Seed Funding
      Ulta Beauty Reports Record First Quarter 2022 Results
      Happi

      Latest Breaking News From Happi

      Honeywell Addresses Critical Issues Such as Sustainability, Workforce Training and Digitalization
      Monat Global Wins Four Stevie Awards in the 20th Annual American Business Awards
      Coty Expands Vegan Beauty Portfolio With New Rimmel Mascara
      Ink World

      Latest Breaking News From Ink World

      UK-Based Caps Cases Installs World’s First EFI Nozomi 14000 LED Digital Corrugated Press
      Sonoco Announces Transition of Chief Financial Officer
      Azelis Expands Presence in India
      Label & Narrow Web

      Latest Breaking News From Label & Narrow Web

      Labelexpo Asia 2022 postponed
      Teklynx software helps Top Clean Injection validate labels
      Zeller+Gmelin named Berry Global’s 2021 Ink Supplier of the Year
      Nonwovens Industry

      Latest Breaking News From Nonwovens Industry

      Rael Raises $35M in Series B Funding
      Schobertechnologies Offers Rotary Web-fed Converting Solutions
      Thorne Relaunches Gut Health Test with Microbiome Wipe
      Orthopedic Design & Technology

      Latest Breaking News From Orthopedic Design & Technology

      Toetal Solutions Raises $1.02 Million in New Financing
      ManaMed's ManaSport Wearable Ultrasound Earns FDA Nod
      Ekso Bionics Names Jerome Wong as Interim CFO
      Printed Electronics Now

      Latest Breaking News From Printed Electronics Now

      onsemi Recognized by Fortune 500 for Its Transformation Journey
      LG Display Presents AI-Driven NFT Artwork on Transparent OLED
      Joe Stockunas Joins SEMI as Americas President

      Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

      AD BLOCKER DETECTED

      Our website is made possible by displaying online advertisements to our visitors.
      Please consider supporting us by disabling your ad blocker.


      FREE SUBSCRIPTION Already a subscriber? Login